Literature DB >> 33982579

The role of connexin 37 polymorphism in spontaneous abortion.

M Kníže1, J Piťha, J A Hubacek, T Fait.   

Abstract

Among unique cardiovascular risk factors in women are complications during pregnancy, including miscarriage. Important risk factor is also genetic background. One of powerful candidate genes for cardiovascular disease of atherosclerotic origin (aCVD) is gene for connexin 37 (Cx37) with strong gene-environment interaction including smoking status, that is also strong risk factor for complications in pregnancy including spontaneous abortion (SA). We analyzed association between SA and Cx37 gene polymorphism (1019C>T; Pro319Ser) in 547 fetuses and its potential interaction with smoking status of mothers. Using genetic analyses from women from general population as controls, ORs for T allele, found in our previous studies to be protective against aCVD, were calculated. T allele carriers (fetuses), had OR 0.91 (95 % CI 0.72-1.14) and no interaction with smoking was observed. In conclusion, no significant association between Cx37 polymorphism and SA was observed and no modifying effect of smoking status on this association was detected.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33982579      PMCID: PMC8820557          DOI: 10.33549/physiolres.934566

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  22 in total

1.  The connexin 37 (1019C>T) gene polymorphism is associated with subclinical atherosclerosis in women with type 1 and 2 diabetes and in women with central obesity.

Authors:  J Piťha; J A Hubáček; P Piťhová
Journal:  Physiol Res       Date:  2010       Impact factor: 1.881

Review 2.  Specific metabolic characteristics of women with former gestational diabetes: the importance of adipose tissue.

Authors:  D Vejrazkova; M Vankova; P Lukasova; J Vcelak; V Cirmanova; M Haluzik; B Bendlova
Journal:  Physiol Res       Date:  2017-09-26       Impact factor: 1.881

3.  Analysis of the potential role of Apolipoprotein E polymorphism in genetic predisposition to spontaneous abortion.

Authors:  Jitka Rynekrova; Dita Kasparova; Vera Adamkova; Tomas Fait; Jaroslav A Hubacek
Journal:  Am J Reprod Immunol       Date:  2011-10-05       Impact factor: 3.886

4.  Dysfunction in gap junction intercellular communication induces aberrant behavior of the inner cell mass and frequent collapses of expanded blastocysts in mouse embryos.

Authors:  Kazue Togashi; Jin Kumagai; Emiko Sato; Hiromitsu Shirasawa; Yuki Shimoda; Kenichi Makino; Wataru Sato; Yukiyo Kumazawa; Yasufumi Omori; Yukihiro Terada
Journal:  J Assist Reprod Genet       Date:  2015-04-28       Impact factor: 3.412

Review 5.  Regulation of gap junction connexins in the endometrium during early pregnancy.

Authors:  R Grümmer; E Winterhager
Journal:  Cell Tissue Res       Date:  1998-08       Impact factor: 5.249

Review 6.  Role of connexin 43 in cardiovascular diseases.

Authors:  Pecoraro Michela; Verrilli Velia; Pinto Aldo; Popolo Ada
Journal:  Eur J Pharmacol       Date:  2015-10-20       Impact factor: 4.432

Review 7.  Metabolic cooperation in the ovarian follicle.

Authors:  J Fontana; S Martínková; J Petr; T Žalmanová; J Trnka
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

8.  Reduced expressions of connexin 43 and VEGF in the first-trimester tissues from women with recurrent pregnancy loss.

Authors:  Xiaoping He; Qinfang Chen
Journal:  Reprod Biol Endocrinol       Date:  2016-08-17       Impact factor: 5.211

9.  Early or late pregnancy loss and development of clinical cardiovascular disease risk factors: a prospective cohort study.

Authors:  J Horn; L J Tanz; J J Stuart; A R Markovitz; G Skurnik; E B Rimm; S A Missmer; J W Rich-Edwards
Journal:  BJOG       Date:  2018-09-23       Impact factor: 6.531

Review 10.  Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis.

Authors:  Clare Teresa Oliver-Williams; Emma E Heydon; Gordon C S Smith; Angela M Wood
Journal:  Heart       Date:  2013-03-28       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.